Congratulations #TeamSAMBAI who have been awarded $25m to work across 15 institutions in 3 continents to tackle #cancerdisparities in populations of African ancestry! We are honoured to join forces with this amazing team and contribute to research against such an important cause.
The secret is out! I am absolutely thrilled to announce my participation in TEAM SAMBAI, led by the amazing @MeliD32. Together, we are embarking on a mission to make significant strides in addressing cancer inequalities on a global scale.
We had an incredible launch 🚀of our #SAMBAI PPI event @KingsCollegeLon! Talks by @rickidove, @DrKeertiGedela & patient advocates highlighted the power of inclusion, patient voices🗣️, and bridging research with those it impacts most. Representation drives better #CancerResearch !
🚨 Tune in for EP5 of SAMBAI Speaks 🗣️- highlighting WP4 from @CancerGrand Team SAMBAI tackling global cancer disparities. WP4: Tumor Biology & Immune Profiling ft Dr Nigel Mongan, Dr. Clayton Yates, Dr. Sheeba Irshad & Patient Advocate Alfred Samuels. 6pm GMT/ 1pm ET
Exciting start to the #P4Health project! 🎉 We were delighted to host Dr. Patrycja Gazinska, Biobank Group Lead at @PORT_Wroclaw for the launch of our #HorizonEU collaboration. Her leadership in molecular and computational pathology at PORT sets the stage for groundbreaking work.
During her visit to @kingsmedicine we showcased our biobanking and clinical translation workflows. Key discussions on translational cancer research and the innovative #BIAALCL project with @royalmarsdenNHS highlighted the consortium's innovative potential in Poland and beyond! 🚀
#AACRdisp24 cochair Melissa B. Davis discussed "The Grand Challenge of Cancer Disparities: Progress, Challenges, and the Path Forward" in a keynote address to open the AACR Conference on The Science of Cancer Health Disparities.
@MeliD32
Countdown to the first patient summit of its kind, the @Make2ndsCount secondary breast cancer conference starting tomorrow. Looking forward to learning lots from experts by experience and experts by profession including @cancermedic@FallowfieldLJ#BreastCancer#patientvoice
Today we celebrated the vital work our researchers are doing with a visit to our research unit at @KingsCollegeLon, which is focused on studying triple negative breast cancer.
Thank you to all who attended and to King's College London for hosting us.
ALT Breast Cancer Now supporters together with scientists at Kings College London
ALT Breast Cancer Now supporters together with scientists at Kings College London
A great session on Immune-Monitoring in Haematology; Lessons from solid tumours. Excellent talks by Sheeba Irshad and Jonathan Irish. 👌👌
#EHA2024@SheebaIrshad@jonathanirish
Our latest paper in JAMA Surgery: Tumor-Associated Lymphocytes and Breast Cancer Survival in Black and White Women. We uncovered a bias in survival benefits of TAL leading into forthcoming work on ancestry-associated tumor immunology. Stay tuned!
jamanetwork.com/journals/jam…
Scientists at King's have been chosen by @CancerGrand to receive up to $25m over 5 years to take on two of cancer’s toughest challenges.
The teams PROSPECT and SAMBAI will advance progress in early-onset cancers and cancer inequities.
Find out more ⬇️
kcl.ac.uk/news/two-teams-awa…
The secret is out! I am absolutely thrilled to announce my participation in TEAM SAMBAI, led by the amazing @MeliD32. Together, we are embarking on a mission to make significant strides in addressing cancer inequalities on a global scale.
So proud to be involved in the public Patient Involvement arm of the #SAMBAI project which is one of the recipients of the Cancer Grand Challenge Awards looking at cancer risk and outcomes in diverse populations to reduce cancer inequities including #pancreaticcancer@CancerGrand
Very excited to be part of team SAMBAI. This represents the largest single NCI/CRUK award for cancer inequities ever. For @YemaachiBio to be one of 2 African partners (and the only biotech) responsible for centering large part of this work in Africa is both humbling and exciting.
⚡ We are proud to share that @YemaachiBio and CEO @YawBediako_ , as part of Team SAMBAI, have received a Cancer Grand Challenges award of up to $25 million over five years to advance research on cancer inequities.
Read the full release: lnkd.in/g_Ts6Nbs
I am delighted to share that @CancerGrand Challenges have announced funding for 5 new teams - KOODAC, MATCHMAKERS, PROSPECT, PROTECT, and SAMBAI. They’ll be tackling some of the biggest questions in cancer research.
Read more on their projects here 👇
📢 Announcing five new global #CancerGrandChallenges teams! 📢
We're thrilled to announce five new teams, each receiving up to $25m over five years to tackle some of cancer's toughest challenges.
Meet the teams: bit.ly/3Oqe58O@CR_UK@theNCI
Congratulations to team SAMBAI, led by Dr. Melissa Davis and including NYGC's Dr. Nico Robine and Dr. Marcin Imieliński, for their #CancerGrandChallenges award! SAMBAI was selected by @CancerGrand to tackle the issue of cancer inequities.
Learn more: bit.ly/48IgwLe